SARS-CoV-2 Mpro-IN-20

• UNSPSC Description:

  SARS-CoV-2 Mpro-IN-20 (compound MPI100) is a SARS-CoV-2 main protease inhibitor. SARS-CoV-2 Mpro-IN-20 shows antiviral activity with the EC50 of 3.4 μM[1].

• Target Antigen:

  SARS-CoV

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/sars-cov-2-mpro-in-20.html

• Smiles:

  O=C(N1[C@H](C(N[C@@H](C[C@H]2C(NCC2)=O)C=O)=O)[C@@]3([H])C(C)(C)[C@@]3([H])C1)[C@@H](NC(OCC4=CC=CC=C4)=O)CC5CCCCC5

• Molecular Weight:

  580.71

• References & Citations:

  [1]Blankenship LR, et al. SARS-CoV-2 Main Protease Inhibitors That Leverage Unique Interactions with the Solvent Exposed S3 Site of the Enzyme. ACS Med Chem Lett. 2024;15(6):950-957. Published 2024 May 20.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported